PRNewsWire
12 Feb 2026, 23:56 UTC · 36w ago
Verdict
Headline takes no side. We score GPK −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 98% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Pomerantz LLP is investigating Apogee Enterprises (APOG) for potential securities fraud or other unlawful business practices.
More negative than 98% of claims this week
Apogee's stock price fell 13.89% to close at $32.11 on January 7, 2026, following the release of its Q3 FY2026 financial results.
So whatA nearly 14% single-day decline demonstrates a severe negative market reaction to the company's earnings report and ongoing cost pressures.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More negative than 95% of claims this week
Apogee's CEO cited higher aluminum, restructuring, and health insurance costs as factors that weighed on the company's Q3 FY2026 results.
So whatRising input and operational costs compress margins and signal ongoing headwinds to profitability for the company.
More negative than 92% of claims this week
Which stocks this story touches
More negative than 98% of ticker scores this week
The company is the subject of a filed class action lawsuit.
More negative than 98% of ticker scores this week
The company is facing a securities fraud investigation and a significant stock price drop following disappointing financial results.
More negative than 80% of ticker scores this week
The company is currently under investigation for claims on behalf of investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
−28.5%
Price agrees with the score
$8.72 vs $12.21 close before publication (Feb 12) · not market-adjusted
GPK chart →
